Benzinga's Top #PreMarket Losers

Chimerix Inc CMRX shares dipped 74.70 percent to $9.00 following Phase 3 trial failure. Chimerix announced in a press release that a Phase 3 study for its SUPPRESS of brincidofovir did not achieve a primary endpoint for the prevention of clinically significant cytomegalovirus infection through Week 24 after transplant. Marathon Oil Corporation MRO shares declined 3.09 percent to $13.50. Crude oil futures dipped 2.78 percent to trade at $37.04 a barrel. ConocoPhillips COP fell 2.45 percent to $47.40 in pre-market trading after dropping 0.90 percent on Thursday. Devon Energy Corp DVN shares tumbled 2.14 percent to $32.00 in pre-market trading after slipping 1.45 percent on Thursday. Baidu Inc (ADR) BIDU shares dipped 1.11 percent to $191.77 in pre-market trading after falling 1.32 percent on Thursday.